Clinical trial
Shield Post-Approval Study Protocol
NCT06880055 is registered in ClinicalTrials.gov with Guardant Health, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Shield Post-Approval Study Protocol
- Lead sponsor
- Guardant Health, Inc.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 14, 2025
- Completion date
- December 1, 2030
- Enrollment
- 3,375 (estimated)
- Sites
- 69
Conditions
As the registry lists them; a condition with its own page is linked.
colo-rectal cancer